Molecular detection of ESBLs production and antibiotic resistance patterns in Gram negative bacilli isolated from urinary tract infections

Indian Journal of Pathology and Microbiology

Volumn 57, Issue 2, 2014, Pages 244-248

  Kargar, Mohammad ^b   Jahromi, Mohammad Zareian ^b   Najafi, Akram ^c   Ghorbani Dalini, Sadegh ^a   Kargar, Mehdi ^a  

^a Department of Microbiology Jahrom Branch Young Researcher's and Elit Club   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic resistance; ESBLs

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE SHV; BETA LACTAMASE TEM; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NALIDIXIC ACID; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; BETA LACTAMASE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CITROBACTER; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTER; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GENETIC RESISTANCE; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEUS; PSEUDOMONAS; URINALYSIS; URINARY TRACT INFECTION; AGED; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; SECRETION (PROCESS); VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84903302644     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.134688     Document Type: Article

References (38)

1. Lee SH, Kim JY, Lee GS, Cheon SH, An YJ, Jeong SH, et al. Characterization of blaCMY-11, an AmpC-Type plasmid-mediated beta-lactamase gene in a Korean clinical isolate of Escherichia coli. J Antimicrob Chemother 2002;49:269-73. (Pubitemid 34162616)
2. Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 1997;24(Suppl 1):S19-45.
3. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Kaugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for clinical microbiology laboratory. J Clin Microbiol 2001;39:2206-12. (Pubitemid 32531482)
4. Du-Bois SK, Marriott MS, Amyes SG. TEM-And SHV-derived extendedspectrum beta-lactamases: Relationship between selection, structure and function. J Antimicrob Chemother 1995;35:7-22.
5. Hall BG, Barlow M. Evolution of the serine beta-lactamases: Past, present and future. Drug Resist Updat 2004;7:111-23. (Pubitemid 38736064)
6. Mims C, Playfair J, Roit I, Wakelin D, Williams R. Medical microbiology. Clin Chem Lab Med 1999;36:895.
7. Marra AR, Wey SB, Castelo A, Gales AC, Cal RG, Filho JR, et al. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: Impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis 2006;6:24.
8. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012;18:54-60.
9. Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, et al. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J Antimicrob Chemother 2010;65:465-9.
10. Ramazanzadeh R. Etiologic agents and extended-spectrum betalactamase production in urinary tract infections in Sanandaj, Iran. East J Med 2010:15:57-62.
11. Mobaleghi J, Salomizand H, Beiranvand S, Membari S, Kalantar E. Extended spectrum B-lactamases in urinary isolates of Escherichia coli in fine Iranian hospitals. Asian J Pharm Clin Res 2012:5:35-6.
12. Pakzad I, Ghafourian S, Taherikalani M, Sadeghifard N, Abtahi H, Rahbar M, et al. Qnr prevalence in extended spectrum Beta-lactamases (ESBLs) and none-ESBLs producing Escherichia coli isolated from urinary tract infections in central of Iran. Iran J Basic Med Sci 2011;14:458-64.
13. Irajian G, Jazayeri Moghadas A. Frequency of extended-spectrum beta lactamase positive and multidrug resistance pattern in Gram-negative urinary isolates, Semnan, Iran. Jundishapur J Microbiol 2010;3:107-13.
14. Zaniani FR, Meshkat Z, Naderi Nasab M, Khaje-Karamadini M, Ghazvini K, Rezaee A, et al. The prevalence of TEM and SHV genes among extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae. Iran J Basic Med Sci 2012;15:654-60.
15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-first Informational Supplement. CLSI document M100-S21. Wayne, PA: 2011.
16. Ghasemi Y, Archin T, Kargar M, Mohkam M. A simple multiplex PCR for assessing prevalence of extended-spectrum ß-lactamases producing Klebsiella pneumoniae in intensive care units of a referral hospital in Shiraz, Iran. Asian Pac J Trop Med 2013;6:703-8.
17. Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981;145:1365-73. (Pubitemid 11097357)
18. Melano R, Corso A, Petroni A, Centrón D, Orman B, Pereyra A, et al. Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum beta-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina. J Antimicrob Chemother 2003;52:36-42. (Pubitemid 36850082)
19. Tracz DM, Boyd DA, Bryden L, Hizon R, Giercke S, Van Caeseele P, et al. Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR. J Antimicrob Chemother 2005;55:768-72. (Pubitemid 40691859)
20. Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Perea EJ, Pérez-Cano R, et al. Clinical and molecular epidemiology of extendedspectrum beta-lactamase-producing Escherichia coli as a case of nosocomial infection or colonization: Implications for control. Clin Infect Dis 2006;42:37-45. (Pubitemid 41832077)
21. Akkoyun S, Kuloǧlu F, Tokuç B. Etiologic agents and risk factors in nosocomial urinary tract infections. Bulletin of Microbiol Bul 2008;42:245-54.
22. Cormican M, Morris D, Corbett-Feeeney G, Flynn J. Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection. Diagn Microbiol Infect Dis 1998;32:317-9. (Pubitemid 29062882)
23. Ena J, Arjona F, Martinez-Peinado C, López-Perezagua Mdel M, Amador C. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 2006;68:1169-74. (Pubitemid 44895458)
24. Khurana S, Taneja N, Sharma M. Extended spectrum betalactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 2002;116:145-9. (Pubitemid 36304693)
25. Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban DJ, Badal RE, et al. Susceptibility of European Escherichia coli clinical isolates from intra-Abdominal infections, extended-spectrum ®-lactamase occurrence, resistance distribution, and molecular characterization of ertapenemresistant isolates (SMART 2008-2009). Clin Microbiol Infect 2012;18:253-9.
26. Empel J, Baraniak A, Literacka E, Mrówka A, Fiett J, Sadowy E, et al.; Beta-PL Study Group. Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother 2008;52:2449-54.
27. Varaiya A, Dogra J, Kulkarni M, Bhalekar P. Extended spectrum beta lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in diabetic foot infection. Indian J Med Microbiol 2008;26:281-2.
28. Chaikittisuk N, Munsrichoom A. Extended-spectrum ®-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in children at Queen Sirikit National Institute of Child Health. J Infect Dis Antimicrob Agents 2007;24:107-15.
29. Daoud Z, Hakime N. Prevalence and susceptibility patterns of extendedspectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon. Span J Chemotherapy 2003;16:233-8. (Pubitemid 37011931)
30. Ullah F, Malik SA, Ahmed J. Antibiotic susceptibility pattern and ESBL prevalence in nosocomial Escherichia coli from urinary tract infections in Pakistan. Afr J Biotechnol 2009;8:3921-6.
31. Lal P, Kapil A, Das BK, Sood S. Occurrence of TEM and SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res 2007;125:173-8. (Pubitemid 46563833)
32. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G; Italian ESBL Study Group. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: Implications for resistance to lactams and other antimicrobial drugs. Antimicrob Agent Chemother 2002;46:196-202.
33. Herindrainy P, Randrianirina F, Ratovoson R, Ratsima Hariniana E, Buisson Y, et al. Rectal carriage of extended-spectrum beta-lactamaseproducing gram-negative bacilli in community settings in Madagascar. PLoS One 2011;6:e22738.
34. Shahcheraghi F, Moezi H, Feizabadi MM. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit 2007;13:BR247-50.
35. Mendonça N, Ferreira E, Louro D, Caniça M; ARSIP Participants. Molecular epidemiology and antimicrobial susceptibility of extendedand broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Portugal. Int J Antimicrob Agents 2009;34:29-37.
36. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-betalactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-Associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agent Chemother 2008;52:2818-24.
37. Yazdi M, Nazemi A, Mirinargasi M, Khatami Nejad MR, Sharifi Sh, Babaei Kochaksaraei M. Prevalence of CTX beta-lactamase resistance gene among Escherichia coli, isolated from urinary tract in Tehran. Lab Sci J 2011;4:48-54.
38. Hassan SA, Jamal SA, Kamal M. Occurrence of multidrug resistant and ESBL producing E.coli causing urinary tract infections. J Basic Appl Sci 2011;7:39-43.